feed,title,long_url,short_url
Benzinga,Why Biogen's Fortunes Hinge On Aducanumab Approval,https://www.benzinga.com/analyst-ratings/analyst-color/20/10/18013636/why-biogens-fortunes-hinge-on-aducanumab-approval,https://j.mp/3kmJN64
